Skip to content

Opportunities

£50m+
Invested to date
30
Companies in our growing portfolio
4
Profitable exits
1 / 3
P3MO
Raise £500,000 Tax Relief: EIS Status: Open

Enterprise SaaS platform streamlining complex transformation projects — from multi-million-pound drug approval programmes in pharma to large-scale IT upgrades in government. P3MO has generated £1.3m to date. At AstraZeneca, 70+ projects have reduced governance time by 72% and cut reporting effort by 90%.

Learn more

Body Rocket
Raise £350,000 Tax Relief: EIS Status: Open

BodyRocket delivers real-time aerodynamic insights for cyclists previously accessible only to elite teams. A compact, bike-mounted system replaces wind-tunnel testing by capturing high-quality aerodynamic data on every outdoor ride to prevent injury and deliver significant performance gains. Current users include Olympians, elite cycling teams and world champions, including Kristian Blummenfelt (World, Olympic and Ironman champion).

Learn more

Yolk
Raise £600,000 Tax Relief: EIS Status: Open

Portfolio company Yolk is targeting the £25bn food-to-go market.  In One Basket Limited (“Yolk”), is a profitable London food-to-go-brand on a mission to “rescue busy lives from loveless food” by serving restaurant quality sandwiches, speciality coffee and better breakfast options using high-quality ingredients.

Learn more

Join us in supporting early-stage, tax efficient UK companies

We empower investors to stay in control of their capital, choose the companies they back and share in their journey to success.

Unlike most VCs, we are not a fund — we combine institutional-grade diligence and attractive tax benefits with the opportunity to co-invest alongside some of the UK’s leading VC firms. 

“Working with Your VC is collaborative and straightforward. They really take the time to understand our vision and potential."

Ian Humphreys
Founder of Brickflow

Our live VC opportunities

P3MO
Raise £500,000 Tax Relief: EIS Status: Open

Enterprise SaaS platform streamlining complex transformation projects — from multi-million-pound drug approval programmes in pharma to large-scale IT upgrades in government. P3MO has generated £1.3m to date. At AstraZeneca, 70+ projects have reduced governance time by 72% and cut reporting effort by 90%.

Learn more

Body Rocket
Raise £350,000 Tax Relief: EIS Status: Open

BodyRocket delivers real-time aerodynamic insights for cyclists previously accessible only to elite teams. A compact, bike-mounted system replaces wind-tunnel testing by capturing high-quality aerodynamic data on every outdoor ride to prevent injury and deliver significant performance gains. Current users include Olympians, elite cycling teams and world champions, including Kristian Blummenfelt (World, Olympic and Ironman champion).

Learn more

Yolk
Raise £600,000 Tax Relief: EIS Status: Open

Portfolio company Yolk is targeting the £25bn food-to-go market.  In One Basket Limited (“Yolk”), is a profitable London food-to-go-brand on a mission to “rescue busy lives from loveless food” by serving restaurant quality sandwiches, speciality coffee and better breakfast options using high-quality ingredients.

Learn more

What is EIS?

The Enterprise Investment Scheme (EIS) lets UK investors back growth companies with tax relief. Benefits include up to 30% income tax relief, plus Capital Gains, loss and Inheritance Tax advantages.

Learn more

Please note

We want our investors to be fully aware of the downsides of investing as well as the potential benefits. It's therefore important to realise that investing always carries risks, including the loss of capital, illiquidity (the inability to sell assets quickly or without substantial loss in value), lack of dividends and share dilution. Alternative investments should still be made as part of a diversified portfolio.

Learn more